GAMUNEX®-C Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GAMUNEX®-C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX-C, [Immune Globulin ...
FDA批准Talecris Biotherapeutics公司Gamunex-C[免疫球蛋白注射液(人用),10%辛酸酯/色谱纯化]用于皮下注射,治疗原发性免疫缺陷(primary immunodeficiency,PI)。皮下给药途径的获批是对已经获批的用于治疗PI和其他两种适应症(慢性炎性脱髓鞘性多神经病和特发性血小板减少性紫癜)的静脉给药途径的补充。中国新药杂志...
Learn about GAMUNEX-C, an intravenous immunoglobulin therapy for CIDP treatment. GAMUNEX-C (immune globulin injection [human], 10% caprylate/chromatography purified)
Gamunex-C package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Learn about GAMUNEX-C, a CIDP, and PIDD treatment option, its efficacy, safety information and patient support. |GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified)
Gamunex-C (Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified]) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.
FDA批准Talecris Biotherapeutics公司Gamunex-C[免疫球蛋白注射液(人用),10%辛酸酯/色谱纯化]用于皮下注射,治疗原发性免疫缺陷(primary immunodeficiency,PI)。皮下给药途径的获批是对已经获批的用于治疗PI和其他两种适应症(慢性炎性脱髓鞘性多神经病和特发性血小板减少性紫癜)的静脉给药途径的补充。 关键词: 原发性...
Learn about GAMUNEX-C, a CIDP, and PIDD treatment option, its efficacy, safety information and patient support. |GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified)
FDA批准Talecris Biotherapeutics公司Gamunex-C[免疫球蛋白注射液(人用),10%辛酸酯/色谱纯化]用于皮下注射,治疗原发性免疫缺陷(primary immunodeficiency,PI).皮下给药途径的获批是对已经获批的用于治疗PI和其他两种适应症(慢性炎性脱髓鞘性多神经病和特发性血小板减少性紫癜)的静脉给药途径的补充.VIP中国新药杂志...
JeffWilleyKatherineTullGlennStevensonMonaParksSDOSJournal of Allergy and Clinical Immunology† WILLIAMS M. ET AL: " REMOVAL OF COAGULATION FACTORS BY THE GAMUNEX (R)-C PURIFICATION PROCESS ", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 131, no. 2, February 2013 (2013-02-01), pages AB...